Steven C. Gilman
Insider Reports History
- Location
- Lexington, MA
- Signature
- /s/ Robert F. Joyce Jr., by Power of Attorney
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Steven C. Gilman:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vericel Corp | Director | Common Stock | 11,000 | $454,960 | $41.36 | 16 Oct 2024 | Direct |
| Akebia Therapeutics, Inc. | Director | Common Stock | 152,830 | $400,414 | $2.62 | 10 Jun 2025 | Direct |
| SCYNEXIS INC | Director | Common stock | 70,000 | $67,200 | $0.9600 | 26 Jun 2025 | Direct |
| Vericel Corp | Director | Restricted Stock Unit | 3,200 | $57,600 | $18.00 | 01 May 2024 | Direct |
| Akebia Therapeutics, Inc. | Director | Stock Option (Right to buy) | 53,600 | 10 Jun 2025 | Direct | ||
| CONTRAFECT Corp | Director | Options (Right to Buy) | 42,000 | 17 May 2022 | Direct | ||
| SCYNEXIS INC | Director | Stock Option | 23,000 | 26 Jun 2025 | Direct | ||
| Vericel Corp | Director | Stock Option (Right to Buy) | 0 | 16 Oct 2024 | Direct |
Insider Reports Filed by Steven C. Gilman
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SCYX | SCYNEXIS INC | 26 Jun 2025 | 2 | $0 | 4 | Director | 30 Jun 2025, 16:09 |
| AKBA | Akebia Therapeutics, Inc. | 10 Jun 2025 | 2 | $0 | 4 | Director | 11 Jun 2025, 17:14 |
| VCEL | Vericel Corp | 16 Oct 2024 | 3 | -$165,132 | 4 | Director | 18 Oct 2024, 16:05 |
| VCEL | Vericel Corp | 02 Oct 2024 | 3 | -$159,241 | 4 | Director | 04 Oct 2024, 16:06 |
| VCEL | Vericel Corp | 18 Sep 2024 | 3 | -$189,547 | 4 | Director | 20 Sep 2024, 16:05 |
| VCEL | Vericel Corp | 04 Sep 2024 | 3 | -$224,200 | 4 | Director | 05 Sep 2024, 16:06 |
| SCYX | SCYNEXIS INC | 20 Jun 2024 | 2 | $0 | 4 | Director | 21 Jun 2024, 16:08 |
| AKBA | Akebia Therapeutics, Inc. | 06 Jun 2024 | 2 | $0 | 4 | Director | 10 Jun 2024, 16:19 |
| VCEL | Vericel Corp | 01 May 2024 | 4 | $0 | 4 | Director | 03 May 2024, 16:06 |
| SCYX | SCYNEXIS INC | 15 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 16:12 |
| SCYX | SCYNEXIS INC | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 20:00 |
| AKBA | Akebia Therapeutics, Inc. | 06 Jun 2023 | 2 | $0 | 4 | Director | 08 Jun 2023, 16:07 |
| VCEL | Vericel Corp | 03 May 2023 | 2 | $0 | 4 | Director | 05 May 2023, 16:04 |
| VCEL | Vericel Corp | 27 Apr 2023 | 2 | $0 | 4 | Director | 28 Apr 2023, 16:04 |
| SCYX | SCYNEXIS INC | 17 Jun 2022 | 2 | $0 | 4 | Director | 22 Jun 2022, 16:03 |
| AKBA | Akebia Therapeutics, Inc. | 08 Jun 2022 | 2 | $0 | 4 | Director | 09 Jun 2022, 16:58 |
| AKBA | Akebia Therapeutics, Inc. | 03 Jun 2022 | 1 | -$1,653 | 4 | Director | 07 Jun 2022, 16:03 |
| /report/000120919122030206-gilman-steven-c-2022-05-17 | CONTRAFECT Corp | 17 May 2022 | 1 | +$140,700 | 4 | Director | 18 May 2022, 18:04 |
| VCEL | Vericel Corp | 29 Apr 2022 | 1 | -$27,846 | 4 | Director | 02 May 2022, 16:07 |
| VCEL | Vericel Corp | 27 Apr 2022 | 4 | $0 | 4 | Director | 29 Apr 2022, 16:12 |
| VCEL | Vericel Corp | 29 Nov 2021 | 3 | -$177,155 | 4 | Director | 01 Dec 2021, 15:07 |
| VCEL | Vericel Corp | 27 Oct 2021 | 3 | -$234,170 | 4 | Director | 28 Oct 2021, 16:12 |
| VCEL | Vericel Corp | 30 Sep 2021 | 3 | -$225,555 | 4 | Director | 01 Oct 2021, 16:12 |
| SCYX | SCYNEXIS INC | 16 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 08:29 |
| AKBA | Akebia Therapeutics, Inc. | 07 Jun 2021 | 1 | -$15,163 | 4 | Director | 09 Jun 2021, 16:26 |
| AKBA | Akebia Therapeutics, Inc. | 02 Jun 2021 | 2 | $0 | 4 | Director | 03 Jun 2021, 17:26 |
| /report/000120919121034651-gilman-steven-c-2021-05-18 | CONTRAFECT Corp | 18 May 2021 | 1 | $0 | 4 | Director | 20 May 2021, 19:48 |